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Background/aim: This study aimed to differentiate rectal mucinous carcinoma (MC) from nonmucinous rectal adenocarcinoma (AC)
using mean apparent diffusion coefficient (mADC) values obtained with diffusion-weighted imaging.
Materials and methods: Sixty-two pathologically confirmed rectal AC (n = 44) and MC (n = 18) patients were included in this study.
The two groups underwent pelvic MRI to determine the local staging baseline for rectal tumors. Once the region of interest (ROI) was
determined, a border was drawn around each hyperintense tumor (b = 1000 s/mm2 images). Following a repeat of this procedure for
each patient, the ROIs were recorded to apparent diffusion coefficient (ADC) maps, and mADC values were measured. The mADC
was determined per slice, followed by a calculation of whole tumor volume ADC mean using the individual mADC values. The Mann–
Whitney test was performed to compare mADCs for the two groups. A receiver operating characteristic (ROC) curve was generated to
determine the differentiating capacity of ADCs from MC to AC.
Results: The mADC was higher in MC (1.631 ± 0.375 × 10–3 mm2/s) (range: 0.95–2.36 × 10–3 mm2/s) than in AC (0.921 ± 0.157 × 10–3
mm2/s) (range: 0.6–1.48 × 10–3 mm2/s) (P < 0.001). mADCs were effective in distinguishing MC from AC (area under the ROC curve,
0.972 (95% CI : 0.928–1.00)). A threshold of 1.27 × 10–3 mm2/s was set that corresponded with high sensitivity (94.4%) and specificity
(97.7%). Twelve MCs (67%) were predominantly hypointense, and 6 MCs (33%) were seen as mixed signal intensity lesions. Forty ACs
(91%) were observed as hyperintense lesions, and 4 ACs (9%) had mixed signal intensity. There was a significant difference in the signal
intensities between MC and AC (c2 = 54.7, P < 0.001).
Conclusion: MCs and ACs show different diffusion characteristics, which can be distinguished with high sensitivity and specificity and
can help to improve prognostic treatment options.
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1. Introduction
Colorectal carcinoma is a major cause of cancer-related
mortality. Rectal cancer comprises approximately onethird of the cases of colorectal cancer. Adenocarcinomas
comprise 96% of colorectal cancers (1). Mucinous
adenocarcinoma (MC) is a specific rectal cancer subtype,
encompassing 10.0% of all cases, and it is associated with
a poorer prognosis than nonmucinous adenocarcinoma
(AC) (2,3). Tumors are defined as MC when a minimum
of 50.0% mucin-to-tumor volume is determined (4).
Interestingly, MCs have limited response to oncological
treatments (5,6). Therefore, it is important to differentiate
MC from AC.
Diffusion-weighted imaging (DWI) is a version of MRI
based on fluid dynamics and the molecular mechanics of
water mobility (7). The signal intensity increases when
* Correspondence: halecolakoglu83@yahoo.com
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water mobility is restricted, such as in cases of dense
cellularity lesions and poor interstitium (8). The apparent
diffusion coefficient (ADC) is used to quantitate diffusivity
based on the fluid restrictions described above compared
to the surrounding tissues. The measurable data obtained
by DWI can clarify the nature of the lesions in various
parts of the body (9).
Our goal was to investigate the usefulness of ADC
values in order to distinguish MC from AC.
2. Materials and methods
2.1. Patients
This was a retrospective study. We subjected 64 patients
diagnosed with rectal carcinoma to pelvic MRI to determine
the local staging baseline for rectal tumors. The patients
were included in the study based on histopathologically
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(biopsy) proven rectal ACs and MCs. The exclusion
criterion was low MRI quality and data from two patients
could not be used due to artifacts. Therefore, the patient
cohort included 62 patients. Forty-four of these patients
were AC patients (24 males and 20 females; age range
41–80 years [mean: 60 years of age]), and 18 (11 males
and 7 females; age range 19–74 years [mean: 53 years of
age]) were MC patients. The institutional ethics committee
approved this retrospective study, and informed written
consent was obtained from each patient before imaging.
2.2. MR techniques
The patient cohort was subjected to a preexamination
food fast (5–6 h) to reduce bowel peristalsis. Therefore, the
administration of an antiperistaltic agent, rectal cleansing,
and/or an enema was not necessary.
A 3.0-T MRI system (MAGNETOM Verio, Siemens,
Erlangen, Germany) was used to screen patients for rectal
tumors based on previously described parameters. Briefly,
the maximum gradient of 45 mT/m and a slew rate of 200
mT/m per second in all three directions were used, and MR
and DW images were acquired during the same procedure.
All pulse sequence parameters (other than those of DWI
used in this study) are listed in the Table. DW images were
collected using a single-shot multislice echoplanar imaging
sequence with the following parameters: repetition time/
echo time, 6800/75 ms; EPI factor, 78; field of view, 360

× 271 mm; matrix size, 130 × 104; slice thickness, 5 mm;
distance factor, 20%; averages, 4.0; reduction factor, 2.0;
and receiver bandwidth, 2402 Hz/Px. The acquisition time
for the DWI was 265 s.
2.3. Image interpretation: ADC measurement
The maps for the ADC were designed using a
monoexponential decay model with all 3 b-values
included (Siemens, Germany). Regions of interest (ROIs)
of the tumor were traced on the DW images with b =
1000 s/mm2. Once the ROI was determined, a border
was drawn around each hyperintense tumor (b = 1000
s/mm2 images). Following a repeat of this procedure for
each patient, the ROIs were recorded to ADC maps and
mean ADC (mADC) values were measured. The mADC
was determined per slice, followed by a calculation of the
whole tumor volume ADC mean using the individual
mADC values.
2.4. Statistical analysis
Compliance with the normal distribution of data in the
two groups was examined by Shapiro–Wilk test. The data
were not distributed normally. The Mann–Whitney test
was used to compare mADCs for the two groups. The
ROC curve was generated to show the ability of ADCs
to distinguish MC from AC. P < 0.05 was considered
statistically significant. All statistical analyses were
performed using SPPS 15.0. (SPSS Inc., Chicago, IL, USA).

Table. Pulse sequence parameters.

Parameter

Sagittal T2weighted TSE

Axial T2weighted TSE

Oblique axial
T2-weighted TSE
(high resolution)

Oblique coronal
T2-weighted TSE
(high resolution)

T1-weighted
fat suppressed
contrast-enhanced

Matrix size

384 × 307

320 × 240

320 × 240

320 × 240

320 × 240

Slice thickness (mm)

3.50

5.00

3.00

3.00

3.50

Distance factor

15.0%

20.0%

16.0%

16.0%

14.0%

Repetition time (ms)

4500.0

5450.0

5460.0

5180.0

495.0

Echo time (ms)

104.0

93.0

58.0

58.0

12.0

Flip angle (degree)

120.0

150.0

145.0

135.0

140.0

Reduction factor

2.0

2.0

2.0

2.0

2.0

Averages

2.0

3.0

4.0

4.0

2.0

FoV (mm)

220 × 220

220 × 220

180 × 180

180 × 180

200 × 200

Orientation

Sagittal

Axial

Oblique axial

Oblique coronal

Oblique axial

Band width (Hz/Px)

250.0

260.0

260.0

260.0

260.0

Acquisition time (min and s)

4 min, 5 s

2 min, 18 s

4 min, 54s

6 min

3 min, 17 s

FoV: Field of view; TSE: turbo spin echo.
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3. Results
The thickness of the tumor was between 1.5 and 2.7 cm for
ACs (mean: 1.8 cm) and 1.4 and 3 cm for MCs (mean: 2.2
cm). The mADC value was higher for MC (1.631 ± 0.375
× 10–3 mm2/s) (range: 0.95 ± 2.36 × 10–3 mm2/s) than for
AC (0.921 ± 0.157 × 10–3 mm2/s) (range: 0.6–1.48 × 10–3
mm2/s) (P < 0.001). An example of our cases is presented
in Figure 1. Mean ADCs were effective for distinguishing
MC from AC (area under the ROC curve, 0.972 (95%

CI: 0.928–1.00)) (Figure 2). A threshold of 1.27 × 10–3
mm2/s was used due to the high sensitivity (94.4%) and
specificity (97.7%) of distinction. Twelve MCs (67%) were
predominantly hypointense, and 6 MCs (33%) were seen as
mixed signal intensity lesions. Forty ACs (91%) were seen
as hyperintense lesions and 4 ACs (9%) had mixed signal
intensity. There was a significant difference in proportions
in signal intensities between MC and AC (P < 0.001).

Figure 1. a) DW image (b = 1000 s/mm2) shows rectal MC in a 58-year-old male. A representative ROI manual trace is seen in the DW
image. b) ADC map shows the copied representative ROI manual trace for calculating tumor mADC values. c) DW image (b = 1000 s/
mm2) shows rectal AC in a 60-year-old male. A representative ROI manual trace is seen in the DW image. d) ADC map shows the copied
representative ROI manual trace for calculating tumor mADC values.
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Figure 2. A representative ROC curve. A threshold of 1.27 × 10–3 mm2/s was used to
determine high sensitivity (94.4%) and specificity (97.7%).

4. Discussion
Mucin-producing tumors have been described in several
different regions of the body, including the pancreas,
breasts, and ovaries, and they are more aggressive than
ACs (10,11). An analysis of colon and rectum MCs
demonstrated poorer prognosis compared to ACs (12).
Hyngstrom et al. demonstrated that rectum mucinous
tumors have worse survival outcomes (2). The surgical
treatment for MCs is different from that of ACs (13).
Therefore, it is important to differentiate MCs from ACs
before surgery.
Mucinous carcinomas have a high content of mucin
and low cellular density. Although they are malignant, they
have increased ADC value with unrestricted diffusion (14).
We attempted to evaluate this form in rectal carcinomas.
In most studies, ADC measurements were performed
by a variety of methods for ROI placement. Interestingly,
some reports included the volume of the whole tumor
(15–20), whereas others used a single tumor slice for
their analysis (21,22) or small tumor samples (23).
Consequently, it is still unclear whether the entire tumor or
a representative section is enough for ADC measurements
or not. In our study, however, we used the whole tumor

volume, selected and drew an ROI and border, and
determined the signal intensity using b1000 images. Then
we obtained the mADC for each slice and generated the
mADC for the whole tumor volume, which is different
from the single-slice method (24).
Malignant lesions are determined through signal
intensities, which are typically high (associated with a
high b value) and calculated by DWI. Multiple reports
have shown a negative association with ADC and tumor
cellularity (25). Interestingly, rectal MC has a higher ADC
value than AC due to reduced cellularity (26). In our study,
twelve MCs (67%) were predominantly hypointense, and
6 MCs (33%) were seen as mixed signal intensity lesions.
Forty ACs (91%) were seen as hyperintense lesions; 4 ACs
(9%) had mixed signal intensity. There was a significant
difference in proportions in signal intensities between MC
and AC (P < 0.001).
We showed that the mADC value was significantly
higher in MCs (1.631 ± 0.375 × 10–3 mm2/s) (range: 0.95 ±
2.36 × 10–3 mm2/s) than in ACs (0.921 ± 0.157 × 10–3 mm2/s)
(range: 0.6–1.48 × 10–3 mm2/s) (P < 0.001). Furthermore,
our study showed that a threshold of 1.27 × 10–3 mm2/s was
the precise value to produce high sensitivity (94.4%) and
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specificity (97.7 %) of distinction. Nasu et al. used a cut-off
of 1 × 10–3 mm2/s to diagnose MC if the tumors with mean
ADCs of this value or more were diagnosed as MC (26).
Sensitivity and specificity were 93% and 94%, respectively.
The authors used two different b values (0 and 1500 s/
mm2) for DWI, whereas we obtained DW images with 3
different b values (50, 400, and 1000 s/mm2), which we
used routinely in our department for abdominal imaging
at 3.0 T.
The results demonstrated that mucinous tumors were
more common in younger patients (27–29). It is believed
that the genetic make-up of the tumors may be responsible
for and reflect their aggressive nature. Another explanation
may be that early tumors do not present symptoms like
those of more locally advanced tumors due to their
localization (i.e. the bowel wall). For example, mucinous
tumors are more frequently observed at the advanced stage
(30). Wu et al. compared mucinous and nonmucinous
tumors within a cut-off of 39 years. They found that
mucinous tumors were more frequent in patients younger
than 39 years (31). Another study showed an average age

at presentation (54.2 ± 16.25 years) that was statistically
less than that of AC patients (mean age at presentation:
58.73 ± 13.62 years) (32). Dozois et al. demonstrated that
MC patients had an average age at presentation of 42.2
years (33). Interestingly, rectal cancers were more frequent
under the age of 50. In our study, the mean age for MC
patients was 53 years, which was less than that of patients
with AC.
Our study has certain limitations. We assessed a small
number of mucinous carcinoma patients, and the ROIs were
obtained by a single person. Further studies would benefit
from multiple people calculating these measurements.
Several factors, such as ROI shape, partial volume effects,
and MRI equipment affect ADC measurements (34,35).
Another weak point of our study was that the mean age
among the groups was heterogeneous.
MCs and ACs show different diffusion characteristics
that can be distinguished with high sensitivity and
specificity and can help to improve prognostic treatment
options.
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